Clinical Trials Directory

Trials / Terminated

TerminatedNCT05831540

Clinical Decision Support Tools to Increase Human Papillomavirus (HPV) Vaccination in Adolescents in Pharmacies

Clinical Decision Support Tools to Increase HPV Vaccination in Pharmacies

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Fred Hutchinson Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical trial develops and tests how well a clinical decision support (CDS) tool works to increase human papillomavirus (HPV) vaccination of children between the age of 9-17 (adolescents) in pharmacies. HPV vaccination rate in eligible adolescents remains low even though over 90% of the cancers in adults caused by HPV can be prevented by the HPV vaccine. The National Vaccine Advisory Committee recommends HPV vaccinations to be given in pharmacies to increase access to vaccines, but pharmacy processes and lack of awareness of the service among parents impact the use of local pharmacies for HPV vaccinations. Using a focus group may be an effective method to develop a CDS tool and create a process that may be more convenient for parents to get their adolescent's vaccine at their local pharmacy. A CDS tool may make it easier to obtain HPV vaccines, and as a result increase the adolescent HPV vaccination rate and reduce the incidence of cancer caused by HPV.

Detailed description

OUTLINE: Participants are assigned to 1 of 3 groups. Group I: Staff participate in facilitated planning discussions to develop CDS tools on study. (Aim I) Group II: Staff receives CDS tools training and implements CDS tools to facilitate HPV vaccination on study. (Aim II) Group III: Parents complete survey post-intervention on study. (Aim II)

Conditions

Interventions

TypeNameDescription
OTHERDiscussionParticipate in focus group
OTHEREducational ActivityUndergo training to use CDS tool
BEHAVIORALHealthcare ActivityUtilize CDS tool
OTHERSurvey AdministrationComplete survey

Timeline

Start date
2024-02-28
Primary completion
2024-11-22
Completion
2024-11-22
First posted
2023-04-26
Last updated
2024-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05831540. Inclusion in this directory is not an endorsement.